Literature DB >> 14560001

Role of nod2 in the response of macrophages to toll-like receptor agonists.

Anne-Laure Pauleau1, Peter J Murray.   

Abstract

Nod2 (CARD15) is a macrophage-specific protein containing two CARD domains, a large nucleotide binding domain and leucine-rich repeats. Human genetic studies have linked mutations in NOD2/CARD15 with Crohn's disease, although the mechanisms involved are unknown. However, Nod2 has been proposed to directly bind bacterial lipopolysaccharide (LPS) and subsequently act as an activator of NF-kappaB via the association of the CARD domains with Rip2/RICK/CARDIAK. This is hypothesized to constitute a pathogen recognition pathway distinct from Toll-like receptor 4-mediated recognition of LPS. Using targeted mutagenesis, we introduced a mutation to delete the CARD domains of mouse Nod2. Mice lacking Nod2 were indistinguishable from controls and showed no signs of intestinal pathology. Macrophages responded normally to multiple Toll-like receptor agonists in terms of NF-kappaB target activation, mitogen-activated protein kinase activation, and cytokine secretion. However, Nod2(-/-) mice were significantly protected in endotoxin challenge experiments, and Nod2(-/-) macrophages were refractory to muramyl dipeptide stimulation. These results argue that Nod2 does not play an essential, nonredundant role in the response of macrophages to bacterial products but rather plays unexpected roles in regulating systemic responses to pathogens.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14560001      PMCID: PMC207570          DOI: 10.1128/MCB.23.21.7531-7539.2003

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  41 in total

1.  Shaping gene expression in activated and resting primary macrophages by IL-10.

Authors:  Roland Lang; Divyen Patel; John J Morris; Robert L Rutschman; Peter J Murray
Journal:  J Immunol       Date:  2002-09-01       Impact factor: 5.422

Review 2.  Resistance gene signaling in plants--complex similarities to animal innate immunity.

Authors:  Ben F Holt; David A Hubert; Jeffery L Dangl
Journal:  Curr Opin Immunol       Date:  2003-02       Impact factor: 7.486

3.  Cutting edge: CATERPILLER: a large family of mammalian genes containing CARD, pyrin, nucleotide-binding, and leucine-rich repeat domains.

Authors:  Jonathan A Harton; Michael W Linhoff; Jinghua Zhang; Jenny P-Y Ting
Journal:  J Immunol       Date:  2002-10-15       Impact factor: 5.422

4.  Nod1, a CARD protein, enhances pro-interleukin-1beta processing through the interaction with pro-caspase-1.

Authors:  Nam Jin Yoo; Won Sang Park; Su Young Kim; John C Reed; Seong Gon Son; Jung Young Lee; Sug Hyung Lee
Journal:  Biochem Biophys Res Commun       Date:  2002-12-13       Impact factor: 3.575

5.  Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study.

Authors:  Jochen Hampe; Jochen Grebe; Susanna Nikolaus; Camilla Solberg; Peter J P Croucher; Silvia Mascheretti; Jörgen Jahnsen; Björn Moum; Bodo Klump; Michael Krawczak; Muddassar M Mirza; Ulrich R Foelsch; Morten Vatn; Stefan Schreiber
Journal:  Lancet       Date:  2002-05-11       Impact factor: 79.321

6.  CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease.

Authors:  Suzanne Lesage; Habib Zouali; Jean-Pierre Cézard; Jean-Frédéric Colombel; Jacques Belaiche; Sven Almer; Curt Tysk; Colm O'Morain; Miquel Gassull; Vibeke Binder; Yigael Finkel; Robert Modigliani; Corinne Gower-Rousseau; Jeanne Macry; Françoise Merlin; Mathias Chamaillard; Anne-Sophie Jannot; Gilles Thomas; Jean-Pierre Hugot
Journal:  Am J Hum Genet       Date:  2002-03-01       Impact factor: 11.025

7.  Involvement of receptor-interacting protein 2 in innate and adaptive immune responses.

Authors:  Arnold I Chin; Paul W Dempsey; Kevin Bruhn; Jeff F Miller; Yang Xu; Genhong Cheng
Journal:  Nature       Date:  2002-03-14       Impact factor: 49.962

8.  Absence of mutation in the NOD2/CARD15 gene among 483 Japanese patients with Crohn's disease.

Authors:  Keiko Yamazaki; Masakazu Takazoe; Torao Tanaka; Toshiki Kazumori; Yusuke Nakamura
Journal:  J Hum Genet       Date:  2002       Impact factor: 3.172

Review 9.  Interleukin-1beta converting enzyme (caspase-1) in intestinal inflammation.

Authors:  Britta Siegmund
Journal:  Biochem Pharmacol       Date:  2002-07-01       Impact factor: 5.858

10.  Lack of common NOD2 variants in Japanese patients with Crohn's disease.

Authors:  Nagamu Inoue; Kazuo Tamura; Yoshitaka Kinouchi; Yoshihiro Fukuda; Seiichi Takahashi; Yasunori Ogura; Naohiro Inohara; Gabriel Núñez; Yusuke Kishi; Yuji Koike; Tooru Shimosegawa; Takashi Shimoyama; Toshifumi Hibi
Journal:  Gastroenterology       Date:  2002-07       Impact factor: 22.682

View more
  92 in total

1.  The specific JNK inhibitor SP600125 targets tumour necrosis factor-alpha production and epithelial cell apoptosis in acute murine colitis.

Authors:  Kiran Assi; Rex Pillai; Antonio Gómez-Muñoz; David Owen; Baljinder Salh
Journal:  Immunology       Date:  2006-05       Impact factor: 7.397

Review 2.  Emerging significance of NLRs in inflammatory bowel disease.

Authors:  Beckley K Davis; Casandra Philipson; Raquel Hontecillas; Kristin Eden; Josep Bassaganya-Riera; Irving C Allen
Journal:  Inflamm Bowel Dis       Date:  2014-12       Impact factor: 5.325

Review 3.  Paneth cells: their role in innate immunity and inflammatory disease.

Authors:  D A Elphick; Y R Mahida
Journal:  Gut       Date:  2005-12       Impact factor: 23.059

Review 4.  NOD2 regulation of Toll-like receptor responses and the pathogenesis of Crohn's disease.

Authors:  T Watanabe; A Kitani; W Strober
Journal:  Gut       Date:  2005-11       Impact factor: 23.059

5.  Induction of Nod1 and Nod2 intracellular pattern recognition receptors in murine osteoblasts following bacterial challenge.

Authors:  Ian Marriott; Dana M Rati; Samuel H McCall; Susanne L Tranguch
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

Review 6.  Bacterial interactions with cells of the intestinal mucosa: Toll-like receptors and NOD2.

Authors:  E Cario
Journal:  Gut       Date:  2005-04-19       Impact factor: 23.059

7.  NOD takes its toll but stays in the CARDs in Crohn's disease.

Authors:  Friedrich C Luft
Journal:  J Mol Med (Berl)       Date:  2005-08       Impact factor: 4.599

Review 8.  The role of Toll-like receptors in CNS response to microbial challenge.

Authors:  Gregory W Konat; Tammy Kielian; Ian Marriott
Journal:  J Neurochem       Date:  2006-08-08       Impact factor: 5.372

9.  NOD1 expression in the eye and functional contribution to IL-1beta-dependent ocular inflammation in mice.

Authors:  Holly L Rosenzweig; Kellen T Galster; Stephen R Planck; James T Rosenbaum
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-12-13       Impact factor: 4.799

10.  Evidence for the involvement of NOD2 in regulating colonic epithelial cell growth and survival.

Authors:  Sheena-M Cruickshank; Louise Wakenshaw; John Cardone; Peter-D Howdle; Peter-J Murray; Simon-R Carding
Journal:  World J Gastroenterol       Date:  2008-10-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.